-
Johnson & Johnson faces new marketing investigations
- Aug 7, 2012
-
New polypill reduces cholesterol and heart risk for people over 50
- Jul 19, 2012
-
Study compares dabigatran to warfarin in VTE treatment
- May 29, 2012
-
FDA advisory panel under scrutiny for voting against Yaz recall
- Mar 27, 2012
-
Hospital's plan to prevent painkiller abuse
- Aug 8, 2012
-
FDA issues warning after codeine kills children post-surgery
- Aug 16, 2012
-
FDA issues warning after codeine kills children post-surgery
- Aug 16, 2012
-
Artificial retina gives sight to blind mice
- Aug 16, 2012
-
Lucentis approved for diabetic macular edema
- Aug 14, 2012
-
Mayo Clinic: Patients in the dark about prescriptions
- Aug 9, 2012
-
Hospital's plan to prevent painkiller abuse
- Aug 8, 2012
-
Alzheimer's drug disappoints
- Aug 8, 2012
Products lorcaserin stroke Drugs Fosamax Yaz testing Nexavar generic blood clots blindness MenHibrix Urban Avaira statin Johnson & Johnson Travel Medicaid pulomonary embolism blood thinner ADHD bladder cancer internal bleeding Washington hormone replacement therapy colon cancer D.C. Avandia Johnson & Johnson lawsuits type 2 diabetes